Newswire
ภาษาไทย
English-
CISION PR Newswire - AI Adoption in Retail and Sustainability Redefine ...
Businesses must tailor strategies to meet evolving consumer preferences HONG KONG, Oct. 27, 2025 /PRNewswire/ -- While Chinese Mainland consumers living within the Greater Bay Area (GBA) exhib... -
CISION PR Newswire - Chinadailyhk.com: 'Yunnan A Many-Splendored Life' ...
HONG KONG, Oct. 27, 2025 /PRNewswire/ -- Yunnan specialties impressed the world on the sidelines of the Greater Bay Area Conference 2025: Financial Connectivity, Nurturing Talent, Building Cultural Br... -
CISION PR Newswire - Michelin Leads The Smart Mobility Revolution with ...
HO CHI MINH CITY, Vietnam, Oct. 27, 2025 /PRNewswire/ -- Michelin is undergoing a strong transformation by applying AI and smart analytics, helping lead the smart, safe, and sustainable mobility revol... -
CISION PR Newswire - Taiwan Showcases Asia-Pacific Leadership in Circul...
TAIPEI, Oct. 27, 2025 /PRNewswire/ -- The Asia Pacific Circular Economy Roundtable & Hotspot 2025 (APCER & Hotspot 2025) concluded successfully in Taipei. Co-hosted by Taiwan's Ministry of Env... -
CISION PR Newswire - The world's first electric car without metals or m...
What happens if electric vehicles and renewable energy technologies like wind turbines and solar panels suddenly had to be produced entirely without resources from mining? eNimon, the first ele... -
CISION PR Newswire - uSMART Opens Second Branch at Somerset, Broadening...
SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- On 24 October 2025, uSMART Securities (Singapore) Pte. Ltd. ("uSMART SG"), a leading fintech brokerage platform licensed by the Monetary Authority of Si... -
CISION PR Newswire - Ascletis to Present Study Results of ASC30 Oral Ta...
-Multiple posters being presented on Ascletis' small molecule and peptide obesity programs -Full analysis of 28-day multiple ascending dose study of oral GLP-1R small molecule agonist ASC30 as a late-... -
CISION PR Newswire - China's NMPA Grants Breakthrough Therapy Designati...
Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung cancer (sqNSCLC), an aggressive subtype of lung cancer Breakthrough Therapy d... -
CISION PR Newswire - Daewoong Pharmaceutical: Third IDMC Reaffirms Safe...
Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline cha... -
CISION PR Newswire - JinkoSolar Supplied Modules to Trinity Energy for ...
CAMPBELL, Calif., Oct. 27, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (the "Company," or "JinkoSolar") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the worl...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.